| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 4.288 | 9.960 | 17.846 | 7.511 |
| Total Income - EUR | - | - | - | - | - | 0 | 33.712 | 50.577 | 17.846 | 7.511 |
| Total Expenses - EUR | - | - | - | - | - | 108 | 41.065 | 89.695 | 81.043 | 141.464 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -108 | -7.352 | -39.118 | -63.197 | -133.953 |
| Net Profit/Loss - EUR | - | - | - | - | - | -108 | -8.364 | -40.635 | -63.197 | -133.953 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharmafarm Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 19.929 | 6.180 | 37.542 | 37.428 | 64.091 |
| Current Assets | - | - | - | - | - | 6.056 | 26.672 | 38.176 | 77.774 | 102.562 |
| Inventories | - | - | - | - | - | 0 | 3.723 | 4.142 | 6.122 | 9.861 |
| Receivables | - | - | - | - | - | 3.789 | 8.847 | 30.438 | 59.269 | 88.079 |
| Cash | - | - | - | - | - | 2.267 | 14.102 | 3.596 | 12.383 | 4.621 |
| Shareholders Funds | - | - | - | - | - | 1.960 | -6.447 | -47.103 | -110.156 | -243.501 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 24.026 | 39.299 | 122.821 | 225.359 | 410.153 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmafarm Medical S.r.l.